Annexon (ANNX) Stock: Buy, Sell, or Hold?
$4.19
-0.02 (-0.48%)
▼
5d:
-3.23%
30d:
+9.4%
90d:
-20.34%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (26%)
Quality Score
44/100
Position
EXTENDED
30-Day Fair Range
$3.75 – $4.17
Position: EXTENDED
Forward P/E & Valuation
-3.9x
Next 12M consensus est.
Wall Street Target
$17.00
+305.7% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$3.83 / $4.52
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: ANNX shows conflicting indicators. Wait for confirmation before entering.
Smart Money Accumulation
Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →
Signal fired Nov 10, 2026 at $4.14 · last confirmed Nov 10, 2026
Strength: 7.4/10
Get Alerted When ANNX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: ANNX is currently trading at $4.19, which is considered extended relative to its 30-day fair value range of $3.75 to $4.17.
Technical Outlook: Technically, ANNX is in a strong downtrend. Immediate support is located at $3.83, while resistance sits at $4.52.
Market Sentiment: ANNX scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $17.00 (+305.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ANNX is in a strong downtrend. Immediate support is located at $3.83, while resistance sits at $4.52.
Market Sentiment: ANNX scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $17.00 (+305.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$3.75 -
$4.17
Company Quality Score
44/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
26.3%
Trading Range & Key Levels
30-Day Trading Range
$3.75 -
$4.17
Current vs Trading Range
EXTENDED
Support Level
$3.83
Resistance Level
$4.52
Current Trend
Strong Downtrend
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (33/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 305.7% below Wall St target ($17.00)
- WARNING: Composite score 44/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-3.91
Wall Street Target
$17.00
(+305.7%)
Share ANNX Analysis
Share this live ANNX analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (ANNX)
Bullish
2 Retail Mentions
StockTwits Volume
2 msgs
24h retail stream
Last Tracked
Nov 12, 2026
Daily AI digest
AI Retail Discussion Summary:
Wells Fargo named Annexon, Inc. ($ANNX) its top pick in the biotechnology sector, maintaining an Overweight rating with a $27.00 price target. The investment firm is bullish on Annexon's ARCHER II trial for vonaprument in generalized myasthenia gravis (GA), with a 55% probability of success for a positive Month-15 outcome.
Key Retail Themes:
Wells Fargo's bullish stance on $ANNX
ARCHER II trial's potential success
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 7:18 PM ET
Data refreshes hourly during market hours. Next update: 8:18 PM
Data refreshes hourly during market hours. Next update: 8:18 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ANNX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RVMD
Revolution Medicines Inc |
STRONG BUY
25 analysts |
$261 | 53 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
21 analysts |
$95 | 41 HOLD |
|
JANX
Janux Therapeutics Inc |
STRONG BUY
18 analysts |
$32 | 51 HOLD |
|
ACHV
Achieve Life Sciences Inc |
STRONG BUY
12 analysts |
$14 | 56 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
18 analysts |
$72 | 29 SELL |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive ANNX Research Pages
